BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 25121590)

  • 21. Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2.
    Saha A; Murakami M; Kumar P; Bajaj B; Sims K; Robertson ES
    J Virol; 2009 May; 83(9):4652-69. PubMed ID: 19244339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.
    Wang A; Welch R; Zhao B; Ta T; Keleş S; Johannsen E
    J Virol; 2015 Dec; 90(6):2906-19. PubMed ID: 26719268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein.
    Bajaj BG; Murakami M; Cai Q; Verma SC; Lan K; Robertson ES
    J Virol; 2008 Apr; 82(8):4082-90. PubMed ID: 18256156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP.
    Skalska L; White RE; Franz M; Ruhmann M; Allday MJ
    PLoS Pathog; 2010 Jun; 6(6):e1000951. PubMed ID: 20548956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model.
    Romero-Masters JC; Ohashi M; Djavadian R; Eichelberg MR; Hayes M; Bristol JA; Ma S; Ranheim EA; Gumperz J; Johannsen EC; Kenney SC
    PLoS Pathog; 2018 Aug; 14(8):e1007221. PubMed ID: 30125329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The EBNA3 family of Epstein-Barr virus nuclear proteins associates with the USP46/USP12 deubiquitination complexes to regulate lymphoblastoid cell line growth.
    Ohashi M; Holthaus AM; Calderwood MA; Lai CY; Krastins B; Sarracino D; Johannsen E
    PLoS Pathog; 2015 Apr; 11(4):e1004822. PubMed ID: 25855980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ATM/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2/M cell cycle block.
    Choudhuri T; Verma SC; Lan K; Murakami M; Robertson ES
    J Virol; 2007 Jun; 81(12):6718-30. PubMed ID: 17409144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pim kinases are upregulated during Epstein-Barr virus infection and enhance EBNA2 activity.
    Rainio EM; Ahlfors H; Carter KL; Ruuska M; Matikainen S; Kieff E; Koskinen PJ
    Virology; 2005 Mar; 333(2):201-6. PubMed ID: 15721354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EBV epigenetically suppresses the B cell-to-plasma cell differentiation pathway while establishing long-term latency.
    Styles CT; Bazot Q; Parker GA; White RE; Paschos K; Allday MJ
    PLoS Biol; 2017 Aug; 15(8):e2001992. PubMed ID: 28771465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus nuclear antigen 3C (EBNA3C) interacts with the metabolism sensing C-terminal binding protein (CtBP) repressor to upregulate host genes.
    Ohashi M; Hayes M; McChesney K; Johannsen E
    PLoS Pathog; 2021 Mar; 17(3):e1009419. PubMed ID: 33720992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr Virus Proteins EBNA3A and EBNA3C Together Induce Expression of the Oncogenic MicroRNA Cluster miR-221/miR-222 and Ablate Expression of Its Target p57KIP2.
    Bazot Q; Paschos K; Skalska L; Kalchschmidt JS; Parker GA; Allday MJ
    PLoS Pathog; 2015 Jul; 11(7):e1005031. PubMed ID: 26153983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase.
    Knight JS; Sharma N; Robertson ES
    Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18562-6. PubMed ID: 16352731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus nuclear antigen 3C regulates cyclin A/p27 complexes and enhances cyclin A-dependent kinase activity.
    Knight JS; Robertson ES
    J Virol; 2004 Feb; 78(4):1981-91. PubMed ID: 14747563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EBV persistence without its EBNA3A and 3C oncogenes in vivo.
    Murer A; McHugh D; Caduff N; Kalchschmidt J; Barros M; Zbinden A; Capaul R; Niedobitek G; Allday M; Chijioke O; Münz C
    PLoS Pathog; 2018 Apr; 14(4):e1007039. PubMed ID: 29709016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Epstein Barr nuclear antigen EBNA3C regulates transcription, cell transformation and cell migration.
    Subramanian C; Knight JS; Robertson ES
    Front Biosci; 2002 Mar; 7():d704-16. PubMed ID: 11861219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptional and epigenetic modulation of autophagy promotes EBV oncoprotein EBNA3C induced B-cell survival.
    Bhattacharjee S; Bose P; Patel K; Roy SG; Gain C; Gowda H; Robertson ES; Saha A
    Cell Death Dis; 2018 May; 9(6):605. PubMed ID: 29789559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
    Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
    J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidative stress enables Epstein-Barr virus-induced B-cell transformation by posttranscriptional regulation of viral and cellular growth-promoting factors.
    Chen X; Kamranvar SA; Masucci MG
    Oncogene; 2016 Jul; 35(29):3807-16. PubMed ID: 26592445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth.
    Maruo S; Wu Y; Ito T; Kanda T; Kieff ED; Takada K
    Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4419-24. PubMed ID: 19237563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines.
    Knight JS; Lan K; Subramanian C; Robertson ES
    J Virol; 2003 Apr; 77(7):4261-72. PubMed ID: 12634383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.